Welcome!

Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired . via: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


News Feed Item

CSE: 2017-1117 - Fundamental Change - Gravis Energy Corp./Biocure Technology Inc.

TORONTO, ONTARIO -- (Marketwired) -- 11/28/17 -- Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.

Listing and disclosure documents will be available at thecse.com on the trading date.

Biocure is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting clinical trials of its biosimilar candidates of Interferon Beta 1b, Filgrastim and Ranibizumab.

Biocure Technology Inc., l'emetteur resultant d'un changement fondamental de Gravis Energy Corp. a ete approuve pour inscription.

Les documents de divulgation et d'inscription seront disponibles a thecse.com a la date de negociation.

Biocure est une societe biopharmaceutique specialisee dans le developpement et la commercialisation de produits biosimilaires majeurs. Biocure mene actuellement des essais cliniques de ses candidats biosimilaires d'interferon beta 1b, de filgrastim et de ranibizumab.


Issuer/Emetteur:                      Biocure Technology Inc.
Security Type/Titre:                  Common Shares/Actions ordinaires
Symbol(s)/Symbole(s):                 CURE
Number of securities issued and
outstanding/ Titres emis et en        93 387 632
circulation:
Number of Securities reserved for
issuance/ Titres reserves pour        3 790 680
emission:
CSE Sector/Categorie:                 Life Sciences/Sciences biologiques
CUSIP:                                09075T 10 7
ISIN:                                 CA 09075T 10 7 5
Boardlot/Quotite:                     500
Trading Currency/Monnaie de
negociation:                          CDN$/$CDN
Trading Date/Date de negociation:     le 29 novembre/November 2017
Other Exchanges/Autres marches:       N/A
Fiscal Year end /Cloture de l'exercice
financier:                            December 31/Le 31 decembre
Transfer Agent/Agent des transferts:  Computershare Trust Company of Canada

Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.